Client:

MediStem

Project:

  • Logo

  • Web-site

  • Presentation template

  • Business card template

Role: Conception, Design, Web-programming, SEO Year: 2013 Logo represents the life wave that is bringing therapeutic cell. After re-branding, company was acquired by Intrexon Corporation (NYSE:XON), a leader in synthetic biology, for approximately $26 million.

Medistem, Inc., is a private company focused on the development of the Endometrial Regenerative Cell (ERC), a universal donor adult stem cell product. ERCs possess specialized abilities to stimulate new blood vessel growth and can differentiate into lung, liver, heart, brain, bone, cartilage, fat and pancreatic tissue. These unique properties have applications for treatment of critical limb ischemia (CLI), congestive heart failure (CHF), neurodegenerative diseases, liver failure, kidney failure, and diabetes. ERCs have been cleared by the FDA to begin studies in the United States. In March 2014, Medistem Inc. was acquired by Intrexon Corporation (NYSE:XON), a leader in synthetic biology, for approximately $26 million. Pursuant to the definitive agreement, Medistem stockholders will receive in exchange for each share of Medistem common stock $0.27 in cash and $1.08 worth of Intrexon common stock, based on the 20-day volume-weighted average price of Intrexon’s common stock immediately prior to closing.